"GLIMITERIS TRIO: Control Diabetes with Triple Action"

GLIMITERIS TRIO 0.2 /  0.3

Voglibose 0.2 / 0.3 mg , Glimepiride 3 mg & Metformin Hydrochloride 500 mg

Introduction to GLIMITERIS TRIO 0.2 / 0.3

GLIMITERIS TRIO 0.2 / 0.3 combines Voglibose, Glimepiride, and Metformin Hydrochloride, forming a powerful triple-action formula designed to manage blood sugar levels in individuals with type 2 diabetes. This combination offers a synergistic approach to diabetes management, targeting different aspects of the disease for optimal control.

Voglibose 0.2 / 0.3 mg in GLIMITERIS TRIO

Usage and Benefits:

• Postprandial Glucose Control: Voglibose helps in reducing the spike in blood glucose levels after meals by delaying carbohydrate absorption.
• Lower Glycemic Index: It assists in achieving a more stable glycemic profile throughout the day.

Glimepiride 3 mg in GLIMITERIS TRIO

Usage and Benefits:

• Insulin Secretion: Glimepiride stimulates the pancreas to produce more insulin, thus reducing blood sugar levels.
• Long-term Efficacy: Proven to maintain its blood sugar-lowering effect over prolonged use.

Metformin Hydrochloride 500 mg in GLIMITERIS TRIO

Usage and Benefits:

• Improved Insulin Sensitivity: Metformin increases the body's sensitivity to insulin, allowing for more effective glucose management.
• Weight Management: Often contributes to weight stability or modest weight loss, which is beneficial for diabetic patients.

Comprehensive Benefits of GLIMITERIS TRIO 0.2 / 0.3

• Enhanced Blood Sugar Control: The combination of these three active ingredients targets different mechanisms of action, providing a comprehensive approach to managing type 2 diabetes.
• Reduced Risk of Complications: Effective management of blood glucose levels with GLIMITERIS TRIO can lower the risk of diabetes-related complications.
• Convenient Dosage: Combining three medications into one pill enhances patient compliance and simplifies the treatment regimen.

In conclusion, GLIMITERIS TRIO 0.2 / 0.3 offers a multifaceted approach to diabetes management by combining the strengths of Voglibose, Glimepiride, and Metformin Hydrochloride. This powerful trio works in harmony to provide effective blood sugar control, potentially reducing the risk of diabetes-related complications and improving the quality of life for those managing type 2 diabetes.  A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

  BUY NOW